カテゴリ： MarketLine, ドイツ, 企業調査

Lanxess AG：企業の戦略・SWOT・財務情報

◆英語タイトル：Lanxess AG - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C3715
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：50
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ドイツ
◆産業分野：化学
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Lanxess AG – Strategy, SWOT and Corporate Finance Report
Summary

Lanxess AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Lanxess AG (Lanxess or ‘the company’) is a leading specialty chemicals company. The company’s product portfolio comprises chlorobenzenes, chlorotoluenes, cresols, nitrotoluenes and their derivatives, amines, benzyl products, hydrofluoric acid, maleic anhydride, hydrazine hydrate, trimethylol propane and hexandiol. It also supplies synthetic rubbers through ARLANXEO, a joint venture with Saudi Aramco. The company’s products find applications in the areas of agrochemicals, automotive, construction, aromas and flavors, pharmaceuticals, tire chemicals, electrical, electronics and medical equipment, leather processing and water treatment, among others. Lanxess operates across Europe, the Middle East and Africa (EMEA), North America, Latin America and Asia-Pacific. Lanxess is headquartered in Cologne, North Rhine-Westphalia, Germany.

Scope

- Detailed information on Lanxess AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Lanxess AG in the form of a SWOT analysis
- An in-depth view of the business model of Lanxess AG including a breakdown and examination of key business segments
- Intelligence on Lanxess AG’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Lanxess AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Lanxess AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Lanxess AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Lanxess AG’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Lanxess AG: Company Overview 9
Lanxess AG: Overview and Key Facts 9
Lanxess AG: Overview 9
Lanxess AG: Key Facts 9
Lanxess AG: Key Employees 11
Lanxess AG: Key Employee Biographies 12
Lanxess AG: Major Products and Services 18
Lanxess AG: Company History 19
Lanxess AG: Management Statement 23
Lanxess AG: Key Competitors 24
Lanxess AG: Company Analysis 25
Lanxess AG: Business Description 25
Lanxess AG: SWOT Analysis 27
Lanxess AG: SWOT Overview 27
Lanxess AG: Strengths 27
Lanxess AG: Weaknesses 28
Lanxess AG: Opportunities 28
Lanxess AG: Threats 29
Lanxess AG: Corporate Financial Deals Activity 31
Lanxess AG: Financial Deals Overview 31
Lanxess AG: Targets and Partners 32
Lanxess AG: Top Deals 2014 – 2018YTD* 33
Lanxess AG: Advisors 34
Lanxess AG: Top Legal Advisors 34
Lanxess AG: Mergers and Acquisitions 35
Lanxess AG: Capital Raising 36
Lanxess AG: Partnership 37
Lanxess AG: Divestments 38
Lanxess AG: Private Equity and Ownership 39
Lanxess AG: Recent Developments 40
Lanxess AG: News and Events Summary 40
Lanxess AG: Business Expansion 43
Lanxess AG: Corporate Governance 44
Lanxess AG: Financial Deals 45
Lanxess AG: Strategy and Operations 45
Appendix 48
Contact Us 48
Methodology 48
About MarketLine 49

List of Tables
Table 1: Lanxess AG: Key Facts
Table 2: Lanxess AG: Key Employees
Table 3: Lanxess AG: Key Competitors
Table 4: Lanxess AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 5: Lanxess AG: M&A Average Deal Size - Value (US$m)
Table 6: Lanxess AG: Targets and Partners
Table 7: Lanxess AG: Top Deals 2014 - 2018YTD*
Table 8: Lanxess AG: Legal Advisor Ranking by Value (US$m)
Table 9: Lanxess AG: M&A Volume and Value Trend (2014 - YTD*2018)
Table 10: Lanxess AG: M&A Activity by Geography (2014 - YTD*2018)
Table 11: Lanxess AG: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 12: Lanxess AG: Capital Raising by Deal Type (2014 - YTD*2018)
Table 13: Lanxess AG: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 14: Lanxess AG: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 15: Lanxess AG: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 16: Lanxess AG: Divestments by Geography (2014 - YTD*2018)
Table 17: Lanxess AG: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 18: Lanxess AG: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 19: Lanxess AG: News and Events Summary
Table 20: Lanxess AG: Business Expansion
Table 21: Lanxess AG: Corporate Governance
Table 22: Lanxess AG: Financial Deals
Table 23: Lanxess AG: Strategy and Operations

List of Figures
Figure 1: Lanxess AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Lanxess AG: M&A Average Deal Size - Value (US$m)
Figure 3: Lanxess AG: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: Lanxess AG: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: Lanxess AG: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 6: Lanxess AG: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 7: Lanxess AG: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 8: Lanxess AG: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 9: Lanxess AG: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 10: Lanxess AG: Divestments by Geography (2014 - YTD*2018)
Figure 11: Lanxess AG: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 12: Lanxess AG: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Lanxess AG：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Bank Hapoalim BM：企業の戦略・SWOT・財務情報
    Bank Hapoalim BM - Strategy, SWOT and Corporate Finance Report Summary Bank Hapoalim BM - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Denka Company Ltd：企業の戦略・SWOT・財務分析
    Denka Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Denka Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Midatech Pharma US Inc-医療機器分野：企業M&A・提携分析
    Summary Midatech Pharma US Inc (Midatech Pharma), formerly DARA BioSciences, Inc., is a pharmaceutical company which focuses on the development and commercialization of cancer treatment and supportive care products. The company’s product portfolio includes Soltamox for the treatment and prevention o …
  • Renata Ltd (RENATA)：企業の財務・戦略的SWOT分析
    Summary Renata Ltd (Renata), formerly Pfizer Bangladesh Ltd, is a pharmaceutical and animal health product company. Its pharmaceutical product portfolio comprises amino acid supplement, anti viral preparation, anti allergic preparations, anti asthmatic preparation, anti bacterial preparations, among …
  • BDI – BioEnergy International AG：企業の戦略的SWOT分析
    BDI - BioEnergy International AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Triangle Energy (Global) Ltd (TEG)：石油・ガス：M&Aディール及び事業提携情報
    Summary Triangle Energy (Global) Ltd (Triangle Energy), formerly Maverick Energy Ltd, is an oil and gas company that explores and produces oil and natural gas reserves. The company operates oil and gas assets such as Reid’s Dome and Pase Field. It holds working interest and operates the Production S …
  • Corizon Health Inc：企業の戦略的SWOT分析
    Corizon Health Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Culture Landmark Investment Ltd
    Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report Summary Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Episurf Medical AB (EPIS B)：医療機器：M&Aディール及び事業提携情報
    Summary Episurf Medical AB (Episurf Medical), formerly Diamorph Medtech AB is a medical technology company that provides patient-specific treatments of painful joint injuries. The company offers diagnosis and design of implants and surgical instruments. Its products include Episealer Femoral Twin, E …
  • MicroPort Scientific Corp (853)：企業の製品パイプライン分析2018
    Summary MicroPort Scientific Corp (MicroPort) a subsidiary of Otsuka Medical Devices Co Ltd is a medical device company which develops, manufactures and markets cardiovascular treatment devices. The company provides products such as cardiovascular devices, orthopedic devices, endovascular devices, e …
  • Infratil Ltd (IFT)-エネルギー分野：企業M&A・提携分析
    Summary Infratil Limited (Infratil) is involved in providing energy, transportation and infrastructure services. The company operates through trustpower, Australian energy, direct connect, Perth energy, Tilt Renewables, Wellington Airport, NZ bus, snapper, infratil property, Metlifecare, RetireAustr …
  • Fibra Uno Administracion, S. A. De C. V.
    Fibra Uno Administracion, S. A. De C. V. - Strategy, SWOT and Corporate Finance Report Summary Fibra Uno Administracion, S. A. De C. V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Zion Oil & Gas Inc (ZN)：企業の財務・戦略的SWOT分析
    Summary Zion Oil & Gas Inc (Zion Oil) is an oil and gas company that explores and produces oil and gas properties in Israel. The company offers services such as geophysical, geological, and other science-based studies and surveys to support oil and gas exploration and development services. It holds …
  • SPR Therapeutics LLC：製品パイプライン分析
    Summary SPR Therapeutics LLC (SPR Therapeutics) is a medical device company that develops and commercializes neurostimulation based therapies and medical devices. The company develops and commercializes therapies for post-surgical pain, neuropathic pain, and musculoskeletal pain. It also provides pe …
  • Bonvests Holdings Limited：戦略・SWOT・企業財務分析
    Bonvests Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Bonvests Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Swedbank AB：企業のM&A・事業提携・投資動向
    Swedbank AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Swedbank AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • BioLineRx Ltd (BLRX)：製薬・医療：M&Aディール及び事業提携情報
    Summary BioLineRx Ltd (BioLineRx) is a clinical stage biopharmaceutical company that focuses on the identification, in-licensing, and development of products to address unmet medical needs. The company focuses mainly on cancer and immunology. Its’s product pipeline includes BL-8040, a short peptide …
  • John Menzies plc：戦略・SWOT・企業財務分析
    John Menzies plc - Strategy, SWOT and Corporate Finance Report Summary John Menzies plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • First Busey Corp：企業の戦略・SWOT・財務情報
    First Busey Corp - Strategy, SWOT and Corporate Finance Report Summary First Busey Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Ziehm Imaging GmbH-医療機器分野：企業M&A・提携分析
    Summary Ziehm Imaging GmbH (Ziehm Imaging) is a medical device company that specializes in the development, production and global marketing of mobile X-ray based imaging solutions. The company's product portfolio includes ziehm vision RFD 3D, ziehm vision RFD hybrid edition, ziehm vision RFD, ziehm …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆